Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Alessandra Criscione is active.

Publication


Featured researches published by Alessandra Criscione.


Future Oncology | 2015

Cytoreductive surgery and hyperthermic intrapleural chemotherapy for malignant pleural diseases: preliminary experience

Marcello Migliore; Damiano Calvo; Alessandra Criscione; cristina Viola; Giuseppe Privitera; Corrado Spatola; Hector Soto Parra; Stefano Palmucci; Nicola Ciancio; Rosario Caltabiano; Giuseppe Di Maria

Cytoreductive surgery and hyperthermic-intraoperative-intrapleural-chemotherapy (HITHOC) is a known approach for malignant pleural diseases (MPD). This study was started to clarify the role of cytoreductive surgery and HITHOC in MPD. Criteria of inclusion were early-stage disease in malignant pleural mesothelioma (MPM), young age, good condition and selected stage-M1a lung cancer. Six patients with MPM and two patients with lung cancer were enrolled. After surgical debulking, intrapleural cisplatin was administered for 60 min at 42.5°C. Wedge, rib resection and repaired diaphragm were added in three, one and one patient, respectively. Morbidity, toxicity and mortality was nil. Hospital stay was 8 days. Mean survival is 13.6 months. This experience confirms that cytoreductive surgery and HITHOC is a good option in the treatment of MPD. A randomized controlled trial is necessary.


Updates in Surgery | 2012

A hybrid single-trocar VATS technique for extracorporeal wedge biopsy of the lingula in patients with diffuse lung disease

Marcello Migliore; Alessandra Criscione; Helen Parfrey

Lung biopsy is the last option to obtain lung tissue for a precise diagnosis in patients with interstitial lung disease (ILD). Several surgical techniques have been reported. The successful application of a hybrid approach is herein reported. The procedure utilizes a single-trocar video-assisted thoracoscopic surgery technique to localize and withdraw the tip of the lingula outside the chest to perform a biopsy in the diagnosis of ILDs. The advantages of this technique over other commonly used methods have also been discussed.


Future Oncology | 2014

Longitudinal and circumferential resection margin in adenocarcinoma of distal esophagus and cardia

Marcello Migliore; Doris Rassl; Alessandra Criscione

Multiple factors are implicated in the long-term survival of patients who have undergone esophagectomy, among these the involvement of longitudinal and circumferential resection margins are well known important prognostic factors. A few studies have assessed the impact of the operative approach on the status of the resection margins, and the data are not well reported, often unclear and, more importantly, there is no scientific evidence or published guideline on what the optimal proximal, distal or circumferential resection margin clearance should be. Owing to the lack of clarity on these points, we undertook a systematic literature review of the impact of longitudinal and circumferential resection margins in patients with operable esophageal cancer, the prognostic significance of margin involvement and the role of neoadjuvant therapy.


Future Oncology | 2015

Preliminary experience with video-assisted thoracic surgery lobectomy for lung malignancies: general considerations moving toward standard practice

Marcello Migliore; Alessandra Criscione; Damiano Calvo; Francesco Borrata; Mariapia Gangemi; Giorgio Attinà

As part of the Second Catania Symposium on Thoracic Oncology, as we started the experience with video-assisted thoracic surgery (VATS) lobectomy for lung malignancies, we reviewed our data and argued some comments in a more general discussion. Operated patients with non-small-cell lung cancer were divided in two groups and compared: VATS (collected in a prospective database) and open (historical group). Out of 74 patients, 31 in group A and 44 in group B. The majority of patients in group A were stage I-II. Mean operative time was shorter in group A. Postoperative hospital stay was shorter in group A. There was no mortality. VATS is effective and safe to perform pulmonary lobectomy in our unit, and it represents our preferred approach for early-stage lung cancer.


Case Reports | 2013

Lung-sparing approach for an intrapulmonary bronchogenic cyst involving the right upper and middle lobes

Alessandra Criscione; Adriana Scamporlino; Damiano Calvo; Marcello Migliore

Intrapulmonary bronchogenic cysts (IBC) represent 20% of abnormal budding of the respiratory tract. Lobectomy is the recommended treatment for IBC in symptomatic adults. We presented a case of a patient with an IBC involving the right upper and middle lobes (RUL–RML). A 27-year-old woman presented with a 2-month history of thoracic pain, cough and haemoptysis. An opacity was found on the chest X-ray. High-resolution CT/MRI showed a 7×4.5 cm marginated mass with an air bubble inside. A video-assisted thoracoscopic surgery was performed. The cyst was neither palpable nor visible. An intraoperative ultrasonography localised the cyst involving the RUL–RML. The lung above the cyst was incised, and a greenish-mucoid content was aspirated. A branch of the superior pulmonary vein was visible. The remaining cystic wall was cauterised. The patient was discharged on day 4. Histology confirmed the IBC. The patient is asymptomatic at a 16-month follow-up. The lung-sparing operation in a young woman with IBC involving the RUL–RML has been beneficial. A long-term follow-up is mandatory.


Future Oncology | 2015

Follicular dendritic cell sarcoma of mediastinum: a key role of radiotherapy in a multidisciplinary approach

Corrado Spatola; Marcello Migliore; Rocco Luca Emanuele Liardo; Roberta Bevilacqua; Raffaele Luigi; Salamone Vincenzo; Alessandra Tocco; Antonio Pagana; Carmelo Militello; Damiano Calvo; Alessandra Criscione; Giuseppe Privitera

Follicular dendritic cell sarcoma is a rare and aggressive tumor and its management is a major clinical challenge. Surgery is considered the mainstay of treatment and no adjuvant approach has demonstrated the ability to reduce the rate of relapses. We report on a case of a man with a 26-year clinical history of mediastinal follicular dendritic cell sarcoma, with several relapses after multiple surgical interventions. The impact of chemotherapy was very small, unlike the radiation therapy that was performed twice, with an interval time of 8 years, through an intensity-modulated technique and an altered fractionation schedule.


Future Oncology | 2015

Pleurectomy/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experience.

Marcello Migliore; Damiano Calvo; Alessandra Criscione; Stefano Palmucci; Giovanni Fuccio Sanzà; Rosario Caltabiano; Corrado Spatola; Giuseppe Privitera; Marco Maria Aiello; Hector Soto Parra; Nicola Ciancio; Giuseppe Di Maria

Cytoreductive surgery and hyperthermic intraoperative intrapleural chemotherapy (HITHOC) are a known option for malignant pleural mesothelioma (MPM). This prospective study was started to prove that pleurectomy/decortication and HITHOC could be successfully performed in a low volume center. Criteria of inclusion were a proven diagnosis of MPM, early-stage disease and good performance status. Six consecutive patients were enrolled. After pleurectomy/decortication, intrapleural cisplatin was administered for 60 min at 42.5 °C. Wedge resections and diaphragmatic reconstruction were added in two and one patient, respectively. Morbidity was 16.6%. Mortality was nil. Hospital stay was 7.8 days. Mean survival was 21.5 months (range: 6-30). This small experience confirms that pleurectomy/decortication and HITHOC are a good therapeutic option in the multimodality treatment of MPM. A randomized controlled trial is necessary.


Asian Cardiovascular and Thoracic Annals | 2014

Two cases of giant solitary fibrous tumor of the pleura: a not-so-rare tumor?

Marcello Migliore; Valerya Okateya; Damiano Calvo; Alessandra Criscione; Borrata Francesco

Solitary fibrous tumors of the pleura are rare intrathoracic neoplasms, especially in the giant form. The treatment of choice remains complete surgical resection which provides a benign clinical outcome. All patients need long-term follow-up due to the possibility of late recurrences. We describe 2 new cases of giant pleural fibrous tumor, which underwent resection via thoracotomy, and discuss the diagnostic and therapeutic modalities.


Updates in Surgery | 2013

Minimal access anterior mediastinotomy

Marcello Migliore; Alessandra Criscione; Damiano Calvo; Tom Routledge

Anterior mediastinotomy and VATS are today the most common surgical approaches to obtain tissue diagnosis or to remove mediastinal lesions. However, both methods lead to inconveniences. This report demonstrates the advantages of a minimal access mediastinotomy to remove or diagnose mediastinal lesions.


Journal of Visceral Surgery | 2017

Single incision extended video assisted transcervical thymectomy

Marcello Migliore; Alessandra Criscione; Marco Nardini; Francesco Patti; Francesco Borrata

In the last 30 years the introduction of VATS in the surgical practice made possible to perform a wide range of thoracic operations including thymectomy. We describe our single incision video-assisted transcervical thymectomy (VATT) for non-thymomatous myasthenia gravis and/or small (<2 cm) intrathymic thymoma in 13 patients. The mean operation time was of 164 minutes (range, 45–275 minutes). The length of hospitalization was 3 days (range, 2–5 days). Decrease of symptoms was obtained in the entire group after a mean follow up of 79 months (range, 8–150 months), and two patients had a complete stable remission. In conclusion, single incision extended transcervical thymectomy (TT) is a safe and successful procedure which allows a complete excision of the anterior mediastinal fat.

Collaboration


Dive into the Alessandra Criscione's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Marco Nardini

James Cook University Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge